Clearmind Medicine Inc. (NASDAQ: CMND) is set to conduct a 1-for-30 reverse share split of its issued and outstanding ordinary shares, no par value, effective starting Nov. 28, 2023.
See Also: Psychedelics Capital Moves: Beckley Waves Raises $3.3M, Clearmind's $2.25M Public Offering
Common shares will be adjusted from 18,221,419 to 607,381. Although no fractional common shares will be issued as a result, current fractional shares will be rounded up to the nearest whole common share; plus a proportionate adjustment to the exercise price and the number of common …
Full story available on Benzinga.com